Template:Myalgia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 121: Line 121:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Toxic epidermal necrolysis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Myalgia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 127: Line 127:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Toxic epidermal necrolysis future or investigational therapies|Future or Investigational Therapies]]
[[Myalgia future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!  
Line 138: Line 138:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Toxic epidermal necrolysis case study one|Case #1]]
[[Myalgia case study one|Case #1]]
|-  
|-  
!
!

Revision as of 18:54, 1 May 2013